MCGAULEY THOMAS 4
4 · TENAX THERAPEUTICS, INC. · Filed Nov 19, 2025
Insider Transaction Report
Form 4
MCGAULEY THOMAS
Interim CFO
Transactions
- Purchase
Common Stock
2025-11-17$7.34/sh+2,000$14,674→ 2,000 total - Purchase
Common Stock
2025-11-17$7.23/sh+5,000$36,140→ 5,000 total(indirect: By Spouse) - Purchase
Common Stock
2025-11-17$7.35/sh+1,000$7,350→ 1,000 total(indirect: By Children)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $7.14 to $7.43. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $7.17 to $7.30. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.